Key Takeaways
- Financial Performance: Bayer Crop Science achieved sales of 21.622 billion euros in 2025, a 1.1% increase on a currency-adjusted basis.
- Corn Sector Growth: The Corn Seed & Traits business rose 13.2%, fueled by strong global performance and a licensing resolution with Corteva.
- Portfolio Challenges: Sales in Soybean and Cotton seeds declined significantly due to the vacatur of the dicamba-based label in the United States.
- Strategic Savings: Bayer is implementing a “Dynamic Shared Ownership” model, targeting 2 billion euros in organizational savings.
- Litigation Progress: The company recently announced a class settlement agreement to resolve current and future Roundup™ (glyphosate) claims.
Corn and Vegetable Seeds Bolster Bayer's Crop Science Portfolio
Bayer reported that its agricultural division, Crop Science, met its full-year 2025 targets despite a complex regulatory and market environment. Growth was primarily led by the Corn Seed & Traits segment, which saw double-digit gains across all global regions. This surge was supported by robust product performance and an increase in planted surface area.
Vegetable Seeds also contributed positively to the Bayer topline, with sales advancing 7.5% due to higher pricing and volumes. While herbicide sales remained stable—including glyphosate-based products—the division faced headwinds in fungicides and insecticides, the latter impacted by the expiration of the Movento™ registration in Europe.
Regulatory Headwinds Impact Soybean and Cotton Sales
Bayer experienced anticipated declines in its Soybean Seed & Traits (-7.7%) and Cotton Seed (-22.9%) sectors. These losses were directly attributed to the legal vacatur of the label for dicamba-based crop protection products in the U.S. market.
27 Comments